Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
⚗️ Ingredient
Vasopressin
2
Clinical Trials
32
Meta-Analyses
0
PubMed References
Top Conditions Studied with Vasopressin
Critically ill patients 2
post cardiac arrest in adults 2
Hemodynamic instability is a frequent complication in patien 1
Misoprostol Allergy|Oxytocin Allergy|Tranexamic Acid Allergy 1
Septic shock is a life-threatening condition that results fr 1
Heart failure (HF) is associated with impaired quality of li 1
Cardiac Arrest Neonatal 1
Sepsis is a common yet complex disorder that remains one of 1
Sepsis is a “life-threatening organ dysfunction caused by a 1
Critical care medicin 1
Vasopressin in combination with glucocorticoids have been de 1
Sepsis and septic shock are life-threatening conditions with 1
📋 Sample Trials
NCT05738148
Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation
Recruiting · Phase 1
NCT05806307
Methods Decreasing Bleeding in Open Myomectomy
Recruiting · Phase 4
📊 Sample Meta-Analyses
CRD42020178297
Efficacy of Corticosteroids, Vasopressin and Epinephrine combination therapy in patients with post_cardiac arrest: a systematic review of clinical trials
post cardiac arrest in adults
CRD42022296508
Evaluation of the effect of corticosteroids and vasopressin and epinephrine drugs alone or in combination in patients after cardiac arrest in a systematic network review
post cardiac arrest in adults
CRD42013005249
Vasopressin receptor antagonists for the treatment of heart failure
Heart failure (HF) is associated with impaired quality of life, with significant
📚 Sample References
None linked yet.
⚗️ All Ingredient data fields for Vasopressin
⚗️ Identity
Name
Vasopressin
Aliases / Synonyms
8-L-Lysine vasopressin; Pressyn; 3-(Phenylalanine)-8-lysine oxytocin; BDBM627975; CVD-0019448; Q60496436; 6-amino-2-{[(2S)-1-{[(4R,7S,10S,13S,16S,19R)-19-amino-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl]formamido}-N-(carbamoylmethyl)hexanamide
🧪 Chemistry
Molecular Weight
1056.2390
LogP
-4.3291
Drug-likeness
0.047
H-Bond Acceptors
16
H-Bond Donors
13
Rotatable Bonds
19
🔬 Structures
Canonical SMILES
C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)N
Isomeric SMILES
C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)N
InChIKey
BJFIDCADFRDPIO-ZCCHBGLBSA-N
InChI
InChI=1S/C46H65N13O12S2/c47-17-5-4-9-29(40(65)52-22-38(51)63)54-45(70)35-10-6-18-59(35)46(71)34-24-73-72-23-28(48)39(64)55-31(20-26-11-13-27(60)14-12-26)43(68)56-32(19-25-7-2-1-3-8-25)42(67)53-30(15-16-36(49)61)41(66)57-33(21-37(50)62)44(69)58-34/h1-3,7-8,11-14,28-35,60H,4-6,9-10,15-24,47-48H2,(H2,49,61)(H2,50,62)(H2,51,63)(H,52,65)(H,53,67)(H,54,70)(H,55,64)(H,56,68)(H,57,66)(H,58,69)/t28-,29?,30-,31-,32-,33-,34-,35-/m0/s1
🔗 External References
🔍 Raw view — every non-empty column on this row (29 fields)
name
Vasopressin
common names
8-L-Lysine vasopressin; Pressyn; 3-(Phenylalanine)-8-lysine oxytocin; BDBM627975; CVD-0019448; Q60496436; 6-amino-2-{[(2S)-1-{[(4R,7S,10S,13S,16S,19R)-19-amino-13-benzyl-10-(2-carbamoylethyl)-7-(carbamoylmethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}pyrrolidin-2-yl]formamido}-N-(carbamoylmethyl)hexanamide
herb ingredient id
HBIN047763
canonical smiles
C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)N
isomeric smiles
C1C[C@H](N(C1)C(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCCN)C(=O)NCC(=O)N
inchi
InChI=1S/C46H65N13O12S2/c47-17-5-4-9-29(40(65)52-22-38(51)63)54-45(70)35-10-6-18-59(35)46(71)34-24-73-72-23-28(48)39(64)55-31(20-26-11-13-27(60)14-12-26)43(68)56-32(19-25-7-2-1-3-8-25)42(67)53-30(15-16-36(49)61)41(66)57-33(21-37(50)62)44(69)58-34/h1-3,7-8,11-14,28-35,60H,4-6,9-10,15-24,47-48H2,(H2,49,61)(H2,50,62)(H2,51,63)(H,52,65)(H,53,67)(H,54,70)(H,55,64)(H,56,68)(H,57,66)(H,58,69)/t28-,29?,30-,31-,32-,33-,34-,35-/m0/s1
inchikey
BJFIDCADFRDPIO-ZCCHBGLBSA-N
mol wt
1056.2390
num h acceptors
16
num h donors
13
mol logp
-4.3291
num rotatable bonds
19
drug likeness
0.047
tcmid ingredient id
22337
pubchem cid
53477739
drugbank id
DB00067
npass id
NPC240285
📋 Clinical Trials
2 · subject of clinical studyNCT05738148 Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation
→ Cardiac Arrest Neonatal
NCT05806307 Methods Decreasing Bleeding in Open Myomectomy
→ Misoprostol Allergy|Oxytocin Allergy|Tranexamic Ac
📊 Meta-Analyses
12 · systematic reviewCRD42020178297 Efficacy of Corticosteroids, Vasopressin and Epinephrine combination therapy in
→ post cardiac arrest in adults
CRD42022296508 Evaluation of the effect of corticosteroids and vasopressin and epinephrine drug
→ post cardiac arrest in adults
CRD42013005249 Vasopressin receptor antagonists for the treatment of heart failure
→ Heart failure (HF) is associated with impaired qua
CRD42017067344 Vasopressin as an alternative vasopressor drug in cardiac surgical patients
→ Hemodynamic instability is a frequent complication
CRD42021236094 Efficacy and Safety of Vasopressin and Terlipressin in Preterm Neonates: A Proto
→ In premature neonates of neonatal intensive care u
CRD42017059058 Vasopressin versus catecholaminergic vasopressors in the treatment of vasodilato
CRD42022368373 Efficacy and safety of vasopressin or catecholamines alone or in combination for
→ Sepsis is a “life-threatening organ dysfunction ca
CRD42020208622 Vasopressin or norepinephrine in vasoplegic shock in surgical patients: Systemat
→ Vasoplegia is a common feature of all advanced sho
CRD42018110903 Discontinuation sequence of norepinephrine and vasopressin in septic shock: a me
→ Septic shock is an high mortality related disease
CRD42016035872 Role of vasopressin and terlipressin in catecholamine resistant shock in the neo
→ Pediatric resistant shock.
CRD42017054324 Effect of vasopressin and analogues on renal outcome in distributive shock
→ Shock.
CRD42017071457 A systematic review of vasopressin (antidiuretic hormone, ADH) versus other anti
→ As the average age of the Canadian population incr
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
ACTIVE — direct link via
herb_ingredients - Ingredient ↔ Target:
ACTIVE — direct link via
ingredient_targets - Target ↔ Disease:
ACTIVE — direct link via
target_health_topics - Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables